Painful knee arthritis to affect almost half of all adults, study indicates
04 Sep 2008

Almost half (46 per cent) of all adults will develop painful osteoarthritis in their knee over the course of their lifetime, it has been suggested.

The longitudinal study to monitor the onset and progression of knee and hip osteoarthritis, published in the September issues of Arthritis Care & Research and carried out by the Arthritis Foundation in the USA, indicates that people who are obese are at greater risk of developing the condition.

Obesity is described by the World Health Organisation as "one of the greatest public health challenges of the 21st century".

No significant differences were noted with regard to gender, race, level of education, but almost two-thirds (65 per cent) of individuals who are obese will get knee osteoarthritis over the course of their lifetime.

Those who have experienced a prior injury to their knee have a lifetime risk of 57 per cent, the study, which was conducted using data from the Thurston Arthritis Research Centre, University of North Carolina-based Johnston County Osteoarthritis Project suggested.

Login and visit the Arthritis Knowledge Centre

Print Article    Bookmark

• Vitamin E supplements do not reduce arthritis risk, study suggests 26/11/08
• Genetic link for psoriatic arthritis "unclear" 22/10/08
• Rheumatoid arthritis linked to joint surgery in the past, study states 03/10/08
• Occupational therapy and exercise increase physical activity in osteoarthritis sufferers, study suggests 30/09/08
• Parasitic worm secretion could help in arthritis treatment, researchers say 17/09/08

• HUMIRA 40 mg - 51.61%
  Rheumatoid arthritis Humira in combination with methotrexate, is indicated for: § the treatment of moderate to severe, active rheumatoid arthritis in adult patients when the response to disease-modifying anti-rheumatic drugs including methotrexate has been inadequate. § the treatment of severe ...
  
  
• ECONAC - 51.61%
  ... in a wide range of conditions, including: arthritic conditions such as rheumatoid arthritis, osteo-arthritis, ankylosing spondylitis, acute gout; acute musculoskeletal disorders such as peri-arthritis (eg, frozen shoulder), tendinitis, tenosynovitis, bursitis; other painful conditions resulting from ...
  
  
• INDOCID - 49.42%
  Indocid Capsules and Indocid Suppositories: Rheumatoid arthritis, osteoarthritis, degenerative joint disease of the hip, ankylosing spondylitis, acute gouty arthritis, lumbago, acute peri-articular disorders, orthopaedic procedures. Dysmenorrhoea. Indocid-R: As above except acute gouty arthritis ...
  
  
• MOBIC - 48.68%
  ... symptomatic treatment of rheumatoid arthritis (chronic polyarthritis); symptomatic treatment of ankylosing spondylitis. Mobic Tablets: Osteoarthritis, 7.5 mg once daily at mealtimes. Increase if necessary to maximum 15 mg once daily. Rheumatoid arthritis, ankylosing spondylitis, 15 mg once daily ...
  
  
• ARCOXIA Film-coated Tablets - 47.95%
  For the symptomatic relief of osteoarthritis (OA), rheumatoid arthritis (RA) and the pain and signs of inflammation associated with acute gouty arthritis. The decision to prescribe a selective COX-2 inhibitor should be based on an assessment of the individual patient's overall risks (See ...
  
  
• PLAQUENIL - 47.95%
  Rheumatoid arthritis, juvenile rheumatoid arthritis, lupus erythematosus. Skin conditions erythematosus. Skin conditions aggravated by sunlight ...